IP Verse

Zentiva Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by Zentiva Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2825558	Combination Therapy For The Treatment Of Ovarian Cancer	F HOFFMANN LA ROCHE	Aug 28, 2024
EP3351246	Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis	NOVARTIS	Sep 16, 2019

Explore the latest publications and patents granted to Zentiva Pharma, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Zentiva Pharma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Zentiva Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ZENTIVA PHARMA	2	-	-	-
F HOFFMANN LA ROCHE	16	140	-	-
NOVARTIS	6	422	-	21